Scroll To Top
Search by Speciality

4th International Diabetic Foot Conference

JW Marriott Dubai * | dubai, UAE
From 0 to 0 AED
Event Preview
EXPIRED
This event
is Finished
Title: 4th International Diabetic Foot Conference
Specialty: , Endocrinology
Dates: From Nov, 14, 2013 to Nov, 15, 2013
Location: dubai, UAE
Type: Conference
Registration Cost: From 0 to 0 AED
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Nov
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Dubai, Uae.
General Info
Event Venue:

JW Marriott Dubai *

Dubai, UAE Visit the Venue to read more
Currency:
AED
Event Overview
Welcome message:

Welcome Message

Following a successful 3rd International Diabetic Foot Conference held in November 2012; we will once again host the International Conference of global experts in the field of diabetic foot care during the 4th International Diabetic Foot Conference (IDFC) taking place from 14-15 November, 2013 in JW Marriott Marquis Hotel Dubai, UAE.

This year’s conference is a continuation from the previous editions where it will highlight international, regional and local speakers who come with a wealth of knowledge to share through plenary sessions, evidence-based and hands-on workshops with breakout sessions to meet the needs of all attendees.

The IDFC has been identified already in the region as a platform for the medical fraternity to get together and update in the field of Diabetic Foot Prevention and Management. Attendees will have the chance to network with experts from around the world.

There have been many recent advances in wound healing specifically at the level of the individual cells. New technologies and therapeutic modalities are promising and will soon be available in routine clinical practice.

We look forward to share it all with you!

Dr. Marwan Al Zarouni
Conference Chair

 

 

On behalf of the IDFC Committee, it is my great pleasure and honor to invite you to the 4 th International Diabetic Foot Conference to be held from 14-15 November, 2013 in Dubai, United Arab Emirates.

Diabetic foot care is a global issue, with its risk factors increasing around the world. Physicians in every country must share their state-of-the-art knowledge of diagnostic, therapeutic, and preventive methods to empower everyone worldwide to fight against the disease. I sincerely hope that this conference will successfully spread the awareness.

I am looking forward to your participation in the conference and your great contribution is very much appreciated.

Looking forward to meeting and participating with you at the Congress!

Ms. Mounia Sabasse
Conference Co-Chair

Registration Not yet available Register Now
Accommodation
Scientific Content Up to Date
Submission Info

Abstract Submission

 

Notification on acceptance/rejection: 29 September, 2013
Please note that only electronic submissions are accepted.

Abstract Submission Guidelines

A. General conditions

  1. Abstracts are required for all oral presentations and posters.
  2. Abstracts must be submitted before 1st September, 2013
  3. Max. 6 abstracts with the same presenting author can be submitted. The system allows max 6 abstracts per submitter ID.
  4. Abstracts must be submitted in English.
  5. Accepted abstracts will be published on the conference web site.
  6. Withdrawal of abstracts can only be accepted if notified in writing. It is only possible to withdraw an abstract maximum 14 days after notification on acceptance.

B. Presenting author and registration

  1. The presenting author must register as an active participant for the conference at the latest 14 days after acceptance of an abstract.
  2. IDFC reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration at the latest 14 days after notification on acceptance.
  3. Please note that max. 2 oral presentations and max. 2 poster presentations by the same presenting author will be accepted for presentation at the conference. NB! The presenting author does not have to be the 1st author.

C. Contents of your abstract

  1. The abstract word limit is max. 250 words per abstract. The IDFC 2012 Conference Secretariat reserves the right to edit abstracts that exceed the word limit.
  2. The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
  3. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a "blind" review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.
  4. 4. The abstract must include the following: 
    Aim: Clearly state the purpose of the abstract.
    Methods: Describe your selection of observations or experimental subjects clearly.
    Results: Present your results in a logical sequence in text, table and illustrations.
    Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
  5. All abbreviations must be defined in first use.
  6. Statements such as "results will be discussed" or "data will be presented" cannot be accepted.
  7. Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. IDFC reserves the right to replace any brand name with a generic name without further notice.
  8. Images that are uploaded to follow the abstract are not guaranteed inclusion in the abstract book.

D. Reviewing

  1. The scientific committee will review the abstract.
  2. Notification of acceptance or rejection of the abstract will be sent to all authors 6 weeks prior to the conference.
  3. It is the responsibility of all investigators that all studies are performed with respect to national legislation, international legislation and ethical guidelines both with regards to humans and animals. The IDFC 2013 Scientific Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
  4. Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.

For all enquiries regarding abstracts and speakers, please contact - 
Idfc@mci-group.com

Poster Presentations

Poster Prizes

This award is designed to reward the considerable work that goes into preparing a poster for presentation at the conference.

To be eligible for consideration you must have a paper accepted for poster presentation at the 4th   International Diabetic Foot Conference in Dubai in 2013. Posters that have been submitted/presented elsewhere are not eligible for a poster prize.

A panel of judges will attend the poster sessions, and authors are strongly encouraged to be present at these sessions in order to answer questions concerning their work. The panel will award 1 poster prize.

The value of the poster prize is $1000 USD.

Your accepted poster will automatically be considered for this award, provided that it has not previously been submitted elsewhere.

Editorial Guidelines for Presented Content:
Abstract Submission Guidelines

A. General conditions

  1. Abstracts are required for all oral presentations and posters.
  2. Abstracts must be submitted before 1st September, 2013
  3. Max. 6 abstracts with the same presenting author can be submitted. The system allows max 6 abstracts per submitter ID.
  4. Abstracts must be submitted in English.
  5. Accepted abstracts will be published on the conference web site.
  6. Withdrawal of abstracts can only be accepted if notified in writing. It is only possible to withdraw an abstract maximum 14 days after notification on acceptance.

B. Presenting author and registration

  1. The presenting author must register as an active participant for the conference at the latest 14 days after acceptance of an abstract.
  2. IDFC reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration at the latest 14 days after notification on acceptance.
  3. Please note that max. 2 oral presentations and max. 2 poster presentations by the same presenting author will be accepted for presentation at the conference. NB! The presenting author does not have to be the 1st author.

C. Contents of your abstract

  1. The abstract word limit is max. 250 words per abstract. The IDFC 2012 Conference Secretariat reserves the right to edit abstracts that exceed the word limit.
  2. The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
  3. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a "blind" review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.
  4. 4. The abstract must include the following: 
    Aim: Clearly state the purpose of the abstract.
    Methods: Describe your selection of observations or experimental subjects clearly.
    Results: Present your results in a logical sequence in text, table and illustrations.
    Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.
  5. All abbreviations must be defined in first use.
  6. Statements such as "results will be discussed" or "data will be presented" cannot be accepted.
  7. Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. IDFC reserves the right to replace any brand name with a generic name without further notice.
  8. Images that are uploaded to follow the abstract are not guaranteed inclusion in the abstract book.

D. Reviewing

  1. The scientific committee will review the abstract.
  2. Notification of acceptance or rejection of the abstract will be sent to all authors 6 weeks prior to the conference.
  3. It is the responsibility of all investigators that all studies are performed with respect to national legislation, international legislation and ethical guidelines both with regards to humans and animals. The IDFC 2013 Scientific Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
  4. Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.

For all enquiries regarding abstracts and speakers, please contact - 
Idfc@mci-group.com

 

Sponsors Exhibitors
Sponsors / Supporters

Sponsors & Exhibitors

Gold Sponsors

 

Lohmann & Rauscher (L&R) is a leading international supplier of high quality, forward-looking medical devices and hygiene products - ranging from conventional bandages to modern treatment and nursing systems. Included focus areas are moist wound care, controlled negative-pressure therapy and OR set systems. For the Diabetic Foot Syndrome L&R provides a complete solution consisting of Suprasorb Wound Management products and Cellacast Total Contact Cast system.

Created in 1998 from the merger of two long-established family-owned companies, Lohmann (founded in 1851) and Rauscher (founded in 1899), L&R has over 150 years expertise as a dependable partner and solution provider for its customers.

Currently, L&R has over 4,000 employees worldwide. The corporate group is represented by 39 subsidiaries and shareholdings in 20 countries, and by more than 30 selected partners in 80 countries. The company's headquarters are located at the Rengsdorf (Germany) and Vienna (Austria) sites.

Bronze Sponsor

MEDWAYGroup,
is one of the reputable local distributors working in the Medical , Dental & cosmetic field in MENA Region.
We are working as a distributor and business manager for multinational companies.
We have a powerful staff who could fulfill our mission and always have precise view to our vision

Contact
Organising Agency

Contact Us

For enquiries related to hotel accommodation or other logistics, please contact:

MCI Middle East 
PO Box 124752
tel: +971 4 311 6300
fax: +971 4 311 6301
Dubai, United Arab Emirates
Email: Idfc@mci-group.com

 

Official Event Webpage
Event map
Revelant Events